Drugs / 208136
last change Dec 2010 re-read 2 minutes ago

208136

Developed for
measles · mumps infectious disease · rubella · varicella zoster infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00892775 Jun 2009 → Sep 2010 measles, mumps infectious disease, rubella, varicella zoster infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 208136 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00892775